Celgene, Agios Settle $1B UPenn Cancer Research Suits

Law360, New York (September 4, 2012, 1:19 PM ET) -- Agios Pharmaceuticals Inc. and Celgene Corp. have agreed to settle two lawsuits brought by the University of Pennsylvania in New York federal court over a former university researcher's alleged use of more than $1 billion worth of patentable, university-funded cancer research to form Agios, the companies announced Friday.

While most of the terms of the settlement are confidential, Cambridge, Mass.-based drug developer Agios and the university have drawn up a licensing agreement for intellectual property focused on developing cancer metabolism diagnostic products as part of the...
To view the full article, register now.

DEWEY LIVE BLOG

Follow our exclusive coverage of the trial of the year:

Catch up on the dewey trial here